Crossmark

Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)

Crossref DOI link: https://doi.org/10.1007/s12022-024-09826-z

Published Online: 2024-09-27

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mattiolo, Paola

Bevere, Michele

Mafficini, Andrea

Verschuur, Anna Vera D.

Calicchia, Martina

Hackeng, Wenzel M.

Simbolo, Michele

Paiella, Salvatore

Dreijerink, Koen M. A.

Landoni, Luca

Pedron, Serena

Cingarlini, Sara

Salvia, Roberto

Milella, Michele

Lawlor, Rita T.

Valk, Gerlof D.

Vriens, Menno R.

Scarpa, Aldo

Brosens, Lodewijk A.

Luchini, Claudio
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (26343, 28054, 29829, 26343, 28054, 29829)

KWF Kankerbestrijding (2020-1 12978, 2020-1 12978)

Fondazione Italiana per la ricerca sulle Malattie del Pancreas (J38D19000690001, J38D19000690001)

Ministero della Salute ((RF CO-2019-12369662: CUP: B39C21000370001)

Università degli Studi di Verona
License Information

Text and Data Mining valid from 2024-09-27

Version of Record valid from 2024-09-27
More Information

Article History

Accepted: 10 September 2024

First Online: 27 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below